1
|
Breite C, Melnikov A, Turon A, de Morais A, Bourlot CL, Maire E, Schöberl E, Otero F, Mesquita F, Sinclair I, Costa J, Mayugo J, Guerrero J, Gorbatikh L, McCartney L, Hajikazemi M, Mehdikhani M, Mavrogordato M, Camanho P, Tavares R, Spearing S, Lomov S, Pimenta S, Van Paepegem W, Swolfs Y. A synchrotron computed tomography dataset for validation of longitudinal tensile failure models based on fibre break and cluster development. Data Brief 2021; 39:107590. [PMID: 34877374 PMCID: PMC8627998 DOI: 10.1016/j.dib.2021.107590] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/27/2021] [Accepted: 11/15/2021] [Indexed: 11/18/2022] Open
Abstract
We performed in-situ tensile tests on two carbon fibre/epoxy composites with continuous scanning using synchrotron computed tomography (CT). Both composites were cross-ply laminates, and two specimens were tested for each composite. The voxel size was sufficiently small to recognize individual fibres and fibre breaks. For each test, 16-19 volumes were reconstructed, cropped down to the 0° plies and analysed to track fibre break and cluster development. This dataset provides the last CT volume before failure for each of the four specimens as well as the individual fibre break locations in all reconstructed volumes. These data are then plotted against predictions from six state-of-the-art strength models. The target is that these data become a benchmark for the development of new models, inspiring researchers to set up refined experiments and develop improved models.
Collapse
Affiliation(s)
- C. Breite
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - A. Melnikov
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - A. Turon
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - A.B. de Morais
- Department of Mechanical Engineering, RISCO research unit, University of Aveiro, Campus Santiago, Aveiro 3810-193, Portugal
| | - C. Le Bourlot
- Universite de Lyon, INSA-Lyon, MATEIS, CNRS UMR5510, Villeurbanne F-69621, France
| | - E. Maire
- Universite de Lyon, INSA-Lyon, MATEIS, CNRS UMR5510, Villeurbanne F-69621, France
| | - E. Schöberl
- Engineering Materials, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK
| | - F. Otero
- INEGI, Rua Dr. Roberto Frias, 400, Porto 4200-465, Portugal
| | - F. Mesquita
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - I. Sinclair
- Engineering Materials, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK
| | - J. Costa
- AMADE, Polytechnic School, University of Girona, Campus Montilivi s/n, Girona E-17003, Spain
| | - J.A. Mayugo
- AMADE, Polytechnic School, University of Girona, Campus Montilivi s/n, Girona E-17003, Spain
| | - J.M. Guerrero
- AMADE, Polytechnic School, University of Girona, Campus Montilivi s/n, Girona E-17003, Spain
| | - L. Gorbatikh
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - L.N. McCartney
- Department of Engineering, Materials & Electrical Science, National Physical Laboratory, Teddington, Middlesex TW11 0LW, United Kingdom
| | - M. Hajikazemi
- Department of Materials, Textiles and Chemical Engineering, Faculty of Engineering and Architecture, Ghent University, Technologiepark Zwijnaarde 46, Ghent, Belgium
| | - M. Mehdikhani
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - M.N. Mavrogordato
- Engineering Materials, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK
| | - P.P. Camanho
- INEGI, Rua Dr. Roberto Frias, 400, Porto 4200-465, Portugal
- DEMec, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias, Porto 4200-465, Portugal
| | - R. Tavares
- INEGI, Rua Dr. Roberto Frias, 400, Porto 4200-465, Portugal
- DEMec, Faculdade de Engenharia, Universidade do Porto, Rua Dr. Roberto Frias, Porto 4200-465, Portugal
| | - S.M. Spearing
- Engineering Materials, Faculty of Engineering and Physical Sciences, University of Southampton, Southampton SO17 1BJ, UK
| | - S.V. Lomov
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
| | - S. Pimenta
- Department of Mechanical Engineering, Imperial College London, South Kensington Campus, London SW7 2AZ, United Kingdom
| | - W. Van Paepegem
- Department of Materials, Textiles and Chemical Engineering, Faculty of Engineering and Architecture, Ghent University, Technologiepark Zwijnaarde 46, Ghent, Belgium
| | - Y. Swolfs
- Department of Materials Engineering, KU Leuven, Kasteelpark Arenberg 44 box 2450, Leuven 3001, Belgium
- Corresponding author. @yentlswolfs
| |
Collapse
|
2
|
Lovatel V, Rodrigues E, Otero L, Kós E, Da Siva B, Tavares R, Fonte A, Bueno A, Da Costa E, Fernandez T. Topic: AS06-Prognosis/AS06a-Prognostic factors of outcome and risk assessment. Leuk Res 2021. [DOI: 10.1016/j.leukres.2021.106680.19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
3
|
Pagnano K, Toreli A, Perobelli L, Quixada A, Seguro F, Bendit I, Delamain M, Sapelli J, Moura M, Bortolini J, Lourenço A, Gonçalves N, Conchon M, Nucci F, Oliveira L, Magalhães G, Funke V, Tavares R, Centrone R, Santos F, Fogliatto L, Palma L, Clementino N, Hokama P, Boquimpani C. COVID-19 IN CHRONIC MYELOID LEUKEMIA PATIENTS – BRAZILIAN EXPERIENCE. Hematol Transfus Cell Ther 2020. [PMCID: PMC7603943 DOI: 10.1016/j.htct.2020.10.889] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
4
|
Almeida F, Macedo A, Trigo D, Abreu M, Guimarães M, Luís N, Pinho R, Tavares R. Neurocognitive evaluation using the International HIV Dementia Scale (IHDS) and Montreal Cognitive Assessment Test (MoCA) in an HIV-2 population. HIV Med 2020; 22:212-217. [PMID: 33012065 DOI: 10.1111/hiv.12963] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/30/2019] [Revised: 07/28/2020] [Accepted: 08/26/2020] [Indexed: 10/23/2022]
Abstract
OBJECTIVES We aimed to characterize neurocognitive impairment (NI) in an HIV-2 population using an observational cross-sectional study in four Portuguese hospitals. METHODS Adult HIV-2-infected patients were included. Montreal Cognitive Assessment Test (MoCA) and International HIV Dementia Scale (IHDS) scales were applied for screening of NI. Patient Health Questionnaire-9 (PHQ-9) and Instrumental Activities of Daily Living (IADL) scales were used for assessment of depression and functionality. A multivariate analysis was performed to assess for risk factors for NI. RESULTS Eighty-one patients were included, 50.6% of African origin (n = 41) and 49.4% of Portuguese origin (n = 40). The MoCA scale showed alterations in 81.5% of patients (100% of migrants vs. 62.5% of non-migrants, P < 0.001) and the IHDS scale showed alterations in 42%. Both scales were altered simultaneously in 35.8%. Variables independently associated with NI were age [odds ratio (OR) = 0.885] and migrant status (OR = 9.150). CONCLUSIONS Neurocognitive impairment (both scales altered) was present in 35.8%, which is comparable to what is described for HIV-1. The MoCA performed worse in the migrant population and might not be applicable in this setting.
Collapse
Affiliation(s)
- F Almeida
- Infectious Diseases department, Centro Hospitalar de São João, Porto, Portugal
| | - A Macedo
- Keypoint Group, Lisbon, Portugal
| | - D Trigo
- Infectious Diseases department, Fernando Fonseca Hospital, Amadora, Portugal
| | - M Abreu
- Infectious Diseases department, Centro Hospitalar do Porto, Porto, Portugal
| | - M Guimarães
- Infectious Diseases department, Dr. José de Almeida, Hospital, Cascais, Portugal
| | - N Luís
- Infectious Diseases department, São Bernardo Hospital, Setúbal, Portugal
| | - R Pinho
- Infectious Diseases department, Algarve Hospital Centre, Portimão, Portugal
| | - R Tavares
- Infectious Diseases department, Beatriz Ângelo Hospital, Loures, Portugal
| |
Collapse
|
5
|
Aguiar Lemos SM, Vasconcellos LJ, Tavares R, Escarce AG, Melo EM. Self-perception in health and quality of life: association with social determinants. Eur J Public Health 2020. [DOI: 10.1093/eurpub/ckaa166.447] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Abstract
Abstract
Objective
To investigate self-perceived health, quality of life and its association with social determinants in adults and the elderly.
Methods
Observational analytical cross-sectional study, with a probabilistic sample of 1,129 participants, adults and seniors, stratified by conglomerates, living in a municipality in Minas Gerais, Brazil. The response variables were the questions: 'How do you evaluate your health in the last two months?' and 'How do you evaluate your quality of life in the last two months?'. The explanatory variables were sociodemographic and technical-assistance data. For data analysis, a descriptive analysis of categorical and continuous variables and an association analysis (Chi-Square Pearson test) were performed, statistically significant those with a value of p0.05.
Results
The majority were female, classified the quality of life as good and presented positive self-perception of health. Most were aged between 30 and 39 years old, attended high school, were married, had formal work and family income of up to one minimum wage. The association between self-perceived health and quality of life with social determinants revealed that the interviewees who tended to present positive self-perception of health were female, had up to 39 years of age, studied until high school, received up to five minimum wages and had had between one and two medical consultations in the last 12 months. Regarding quality of life, the interviewees who reported there were good were female, between 30 and 39 years old, with high school, were married, had formal work, received up to two minimum wages and had between one and two medical consultations at last year. The univariate analysis revealed that respondents who said their health was positive also rated the quality of life as good.
Conclusions
In the sample studied, it was observed that positive self-perception of health is associated with good quality of life.
Key messages
Health public. Quality of life.
Collapse
Affiliation(s)
- S M Aguiar Lemos
- Departamento de Fonoaudiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - L J Vasconcellos
- Pós Graduação Promoção da Saúde e Prevenção da Violência, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - R Tavares
- Pós Graduação Promoção da Saúde e Prevenção da Violência, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - A G Escarce
- Departamento de Fonoaudiologia, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| | - E M Melo
- Pós Graduação Promoção da Saúde e Prevenção da Violência, Universidade Federal de Minas Gerais, Belo Horizonte, Brazil
| |
Collapse
|
6
|
Efthimiou G, Andronopoulos S, Tavares R, Bartzis J. CFD-RANS prediction of the dispersion of a hazardous airborne material released during a real accident in an industrial environment. J Loss Prev Process Ind 2017. [DOI: 10.1016/j.jlp.2017.01.015] [Citation(s) in RCA: 24] [Impact Index Per Article: 3.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
7
|
Zhang S, Dang-Tan T, Ismaila A, Tacon C, Daugherty J, Tavares R, Goodall E, Smith S, Stutz M, Vaillancourt J, Parsons D, Lin X, Nadeau G, Simidchiev A, Sampalis J. The Impact of Adherence and Exacerbation Frequency on Health Care Utilization and Associated Direct Costs in Severe Asthma. Chest 2016. [DOI: 10.1016/j.chest.2016.08.927] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
8
|
Bruhn D, Martin AA, Tavares R, Hunt B, Pollock RF. Cost-utility of albiglutide versus insulin lispro, insulin glargine, and sitagliptin for the treatment of type 2 diabetes in the US. J Med Econ 2016; 19:672-83. [PMID: 26882484 DOI: 10.3111/13696998.2016.1154567] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Objective To compare the cost-utility of the glucagon-like peptide-1 receptor agonist albiglutide with those of insulin lispro (both in combination with insulin glargine), insulin glargine, and the dipeptidyl peptidase-4 inhibitor sitagliptin, representing treatments along the type 2 diabetes treatment continuum. Methods The Centre for Outcomes Research and Effectiveness (CORE) Diabetes Model was used for the cost-utility analysis. Data from three Phase 3 clinical trials (HARMONY 6, HARMONY 4, and HARMONY 3) evaluating albiglutide for the treatment of patients with type 2 diabetes were used for the baseline characteristics and treatment effects. Utilities and costs were derived from published sources. Results Albiglutide treatment was associated with an improvement in mean quality-adjusted life expectancy of 0.099, 0.033, and 0.101 years when compared with insulin lispro, insulin glargine, and sitagliptin, respectively. Over the 50-year time horizon, mean total costs in the albiglutide arm were $4332, $2597, and $2223 more than in the other respective treatments. These costs resulted in an incremental cost-utility ratio of $43,541, $79,166, and $22,094 per quality-adjusted life-year (QALY) gained for albiglutide vs insulin lispro, insulin glargine, and sitagliptin, respectively. At a willingness-to-pay threshold of $50,000 per QALY gained, there was a 53.0%, 41.5%, and 67.5% probability of albiglutide being cost-effective compared with the other respective treatments. Limitations This analysis was an extrapolation over a 50-year time horizon based on relatively short-term data obtained during clinical trials. It does not take into account potential differences between the respective treatments in adherence and persistence that can influence both effects and costs. Conclusions Albiglutide represents a reasonable treatment option for patients with type 2 diabetes based on its cost-utility, relative to insulin lispro, insulin glargine, and sitagliptin.
Collapse
Affiliation(s)
- David Bruhn
- a GlaxoSmithKline, Research Triangle Park , NC , USA
| | | | | | - Barnaby Hunt
- d Ossian Health Economics and Communications GmbH , Basel , Switzerland
| | - Richard F Pollock
- d Ossian Health Economics and Communications GmbH , Basel , Switzerland
| |
Collapse
|
9
|
Tavares R, Duclos M, Brabant MJ, Checchin D, Bosnic N, Turvey K, Terres JAR. Differences in self-monitored, blood glucose test strip utilization by therapy for type 2 diabetes mellitus. Acta Diabetol 2016; 53:483-92. [PMID: 26972690 PMCID: PMC4877426 DOI: 10.1007/s00592-015-0823-z] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 07/21/2015] [Accepted: 12/02/2015] [Indexed: 11/03/2022]
Abstract
AIMS To determine whether blood glucose test strip (BGTS) utilization in patients with type 2 diabetes (T2D) is associated with the type of diabetes therapy, classified according to hypoglycemic risk. METHODS A retrospective, longitudinal (2006-2012) study of Canadian private drug plans (PDP) and Ontario Public Drug Programs (OPDP) prescription claims was conducted. Analyses were restricted to patients with T2D with or without a claim for BGTS. Daily BGTS utilization (TS/patient/day) was evaluated by diabetes therapy classified by hypoglycemic risk. Multivariate analyses were conducted to identify determinants of BGTS utilization. RESULTS The T2D cohort comprised 5,759,591 observations from 1,949,129 claimants. Mean BGTS utilization was 0.84 TS/patient/day and differed between PDP and OPDP (0.66 vs. 1.00). Daily utilization was greatest in patients receiving therapy associated with a pre-defined high risk of hypoglycemia [insulin: basal + bolus (2.16), premixed (1.65), basal (1.16), other insulin regimens (2.13), and sulfonylureas (0.74)] versus non-sulfonylurea non-insulin-based regimens (0.52). For non-insulin therapy, BGTS utilization was greater for patients on multiple non-insulin therapies versus monotherapy (0.74 vs. 0.53 TS/patient/day). In multivariate analyses, drivers for BGTS utilization included insulin use, previous BGTS use, and female gender. Previous diabetes therapy and duration of therapy were negatively correlated with BGTS utilization. CONCLUSIONS BGTS utilization varies depending on the type of therapy used to treat T2D according to hypoglycemic risk. Decision making regarding BGTS needs to account for robust analyses of current utilization and its value in those settings, including in patients not receiving diabetes therapy and the prevalence of circumstances conducive to more intensive monitoring.
Collapse
Affiliation(s)
- Ruben Tavares
- GlaxoSmithKline, 7333 Mississauga Road North, Mississauga, ON, L5N 6L4, Canada.
| | - Marc Duclos
- IMS Brogan, a unit of IMS Health, Kirkland, QC, Canada
| | | | - Daniella Checchin
- GlaxoSmithKline, 7333 Mississauga Road North, Mississauga, ON, L5N 6L4, Canada
| | | | | | | |
Collapse
|
10
|
Tomizza MA, Jessome MA, Barbosa J, Beattie KA, Bensen WG, Bobba RS, Cividino AA, Emond PD, Gordon C, Hart L, Ioannidis G, Koh MXP, Larché M, Tavares R, Tytus S, Adachi JD. Assessing the Reliability of a Semiautomated Segmentation Algorithm for Quantifying Erosions in the Metacarpophalangeal Joints of Patients with Rheumatoid Arthritis. J Rheumatol 2015; 42:1582-6. [PMID: 26178277 DOI: 10.3899/jrheum.141139] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 05/13/2015] [Indexed: 11/22/2022]
Abstract
OBJECTIVE Assess the reliability of early erosions in rheumatoid arthritis (EERA) software for quantifying erosive damage to the metacarpophalangeal joints of patients with rheumatoid arthritis (RA). METHODS One hundred magnetic resonance image sets from 68 patients with early referral RA were evaluated. Reliability was assessed using 95% limits of agreement and intraclass correlation coefficient (ICC) with 95% CI. RESULTS Limits of agreement linearly depended on erosion volume: 0.44× between readers and 0.19× within readers. Interrater ICC was 0.976 (95% CI 0.965-0.984) and intrarater ICC was 0.996 (95% CI 0.994-0.997). CONCLUSION EERA is highly reproducible for quantifying erosions in patients with early RA.
Collapse
Affiliation(s)
- Michael A Tomizza
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Matthew A Jessome
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Joshua Barbosa
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Karen A Beattie
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - William G Bensen
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Raja S Bobba
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Alfred A Cividino
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Patrick D Emond
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Chris Gordon
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Lawrence Hart
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - George Ioannidis
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Melissa X P Koh
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Maggie Larché
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Ruben Tavares
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Stephen Tytus
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton
| | - Jonathan D Adachi
- From the Department of Medical Sciences, Department of Medicine, and Faculty of Health Sciences, McMaster University; Department of Diagnostic Imaging, St. Joseph's Healthcare Hamilton, Hamilton, Ontario, Canada.M.A. Tomizza, BSc, Department of Medical Sciences, McMaster University; M.A. Jessome, BHSc; J. Barbosa, BHSc, Faculty of Health Sciences, McMaster University; K.A. Beattie, PhD; W.G. Bensen, MD; R.S. Bobba, MD; A.A. Cividino, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; P.D. Emond, PhD; C. Gordon, PhD, St. Joseph's Healthcare Hamilton; L. Hart, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; G. Ioannidis, PhD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; M.X. Koh, BHSc, Faculty of Health Sciences, McMaster University; M. Larché, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton; R. Tavares, PhD; S. Tytus, MD, St. Joseph's Healthcare Hamilton; J.D. Adachi, MD, Department of Medicine, McMaster University, and St. Joseph's Healthcare Hamilton.
| |
Collapse
|
11
|
Baptista M, Tavares R, Ramalho-Santos J. Spermicidal and microbicidal compounds: in search of an efficient multipurpose strategy. Curr Med Chem 2015; 21:3693-700. [PMID: 25174922 DOI: 10.2174/0929867321666140826115929] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/12/2013] [Revised: 01/11/2014] [Accepted: 08/22/2014] [Indexed: 11/22/2022]
Abstract
The search for cheap, easy-to-use and effective spermicides and microbicides to help avoid unwanted pregnancies and the transmission of sexually transmitted diseases has been ongoing for many years. This review takes into account compounds designed to act both as microbicides and spermicides for multipurpose prevention, and focuses on the required methodological studies to evaluate their safety, especially cytotoxicity. A comprehensive literature review was conducted on the synthesis, development, advantages and disadvantages of vaginal multi-function compounds. The available data shows that after several setbacks, there is a current interest in the synthesis and in the activity of novel dual-function substances. The study of well-known compounds with distinctive mechanisms of action provides a solid starting point to explore the possible development of such strategies. However, a completely safe and efficient compound for commercialization has yet to be identified.
Collapse
Affiliation(s)
| | | | - J Ramalho-Santos
- Department of Life Sciences, University of Coimbra, 3001-401 Coimbra, Portugal.
| |
Collapse
|
12
|
Tavares R, Beattie KA, Bensen WG, Bobba RS, Cividino AA, Finlay K, Goeree R, Hart LE, Jurriaans E, Larche MJ, Parasu N, Tarride JE, Webber CE, Adachi JD. A double-blind, randomized controlled trial to compare the effect of biannual peripheral magnetic resonance imaging, radiography and standard of care disease progression monitoring on pharmacotherapeutic escalation in rheumatoid and undifferentiated inflammatory arthritis: study protocol for a randomized controlled trial. Trials 2014; 15:268. [PMID: 24997587 PMCID: PMC4227117 DOI: 10.1186/1745-6215-15-268] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2014] [Accepted: 06/05/2014] [Indexed: 11/28/2022] Open
Abstract
Background Permanent joint damage is a major consequence of rheumatoid arthritis (RA), the most common and destructive form of inflammatory arthritis. In aggressive disease, joint damage can occur within 6 months from symptom onset. Early, intensive treatment with conventional and biologic disease-modifying anti-rheumatic drugs (DMARDs) can delay the onset and progression of joint damage. The primary objective of the study is to investigate the value of magnetic resonance imaging (MRI) or radiography (X-ray) over standard of care as tools to guide DMARD treatment decision-making by rheumatologists for the care of RA. Methods A double-blind, randomized controlled trial has been designed. Rheumatoid and undifferentiated inflammatory arthritis patients will undergo an MRI and X-ray assessment every 6 months. Baseline adaptive randomization will be used to allocate participants to MRI, X-ray, or sham-intervention groups on a background of standard of care. Prognostic markers, treating physician, and baseline DMARD therapy will be used as intervention allocation parameters. The outcome measures in rheumatology RA MRI score and the van der Heijde-modified Sharp score will be used to evaluate the MRI and X-ray images, respectively. Radiologists will score anonymized images for all patients regardless of intervention allocation. Disease progression will be determined based on the study-specific, inter-rater smallest detectable difference. Allocation-dependent, intervention-concealed reports of positive or negative disease progression will be reported to the treating rheumatologist. Negative reports will be delivered for the sham-intervention group. Study-based radiology clinical reports will be provided to the treating rheumatologists for extra-study X-ray requisitions to limit patient radiation exposure as part of diagnostic imaging standard of care. DMARD treatment dose escalation and therapy changes will be measured to evaluate the primary objective. A sample size of 186 (62 per group) patients will be required to determine a 36% difference in pharmacological treatment escalation between the three groups with intermediate dispersion of data with 90% power at a 5% level of significance. Discussion This study will determine if monitoring RA and undifferentiated inflammatory arthritis patients using MRI and X-ray every 6 months over 2 years provides incremental evidence over standard of care to influence pharmacotherapeutic decision-making and ultimately hinder disease progression. Trial registration This trial has been registered at ClinicalTrials.gov: NCT00808496 (registered on 12 December 2008).
Collapse
Affiliation(s)
- Ruben Tavares
- UNCOVER Clinical Research Company, Milton, ON, Canada.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
13
|
Amorim JH, Rodrigues V, Tavares R, Valente J, Borrego C. CFD modelling of the aerodynamic effect of trees on urban air pollution dispersion. Sci Total Environ 2013; 461-462:541-551. [PMID: 23751336 DOI: 10.1016/j.scitotenv.2013.05.031] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 12/04/2012] [Revised: 04/24/2013] [Accepted: 05/13/2013] [Indexed: 06/02/2023]
Abstract
The current work evaluates the impact of urban trees over the dispersion of carbon monoxide (CO) emitted by road traffic, due to the induced modification of the wind flow characteristics. With this purpose, the standard flow equations with a kε closure for turbulence were extended with the capability to account for the aerodynamic effect of trees over the wind field. Two CFD models were used for testing this numerical approach. Air quality simulations were conducted for two periods of 31h in selected areas of Lisbon and Aveiro, in Portugal, for distinct relative wind directions: approximately 45° and nearly parallel to the main avenue, respectively. The statistical evaluation of modelling performance and uncertainty revealed a significant improvement of results with trees, as shown by the reduction of the NMSE from 0.14 to 0.10 in Lisbon, and from 0.14 to 0.04 in Aveiro, which is independent from the CFD model applied. The consideration of the plant canopy allowed to fulfil the data quality objectives for ambient air quality modelling established by the Directive 2008/50/EC, with an important decrease of the maximum deviation between site measurements and CFD results. In the non-aligned wind situation an average 12% increase of the CO concentrations in the domain was observed as a response to the aerodynamic action of trees over the vertical exchange rates of polluted air with the above roof-level atmosphere; while for the aligned configuration an average 16% decrease was registered due to the enhanced ventilation of the street canyon. These results show that urban air quality can be optimised based on knowledge-based planning of green spaces.
Collapse
Affiliation(s)
- J H Amorim
- CESAM & Department of Environment and Planning, University of Aveiro, 3810-193 Aveiro, Portugal.
| | | | | | | | | |
Collapse
|
14
|
Tavares R, Huang S, Bykerk VP, Bell MJ. A parallel group cohort to determine the measurement properties of an early inflammatory arthritis detection tool. Rheumatology (Oxford) 2013; 52:2077-85. [PMID: 23962625 DOI: 10.1093/rheumatology/ket190] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
Affiliation(s)
- Ruben Tavares
- UNCOVER Clinical Research Company, Milton, Ontario, Canada.
| | | | | | | |
Collapse
|
15
|
Chiarelli L, Tavares R. SAT0556 Predictors of Intensive Anti-Rheumatic Therapy in Early Care for Rheumatoid Arthritis. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2280] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
16
|
Tavares R, Veinot PL, Zummer M, Zhao A, Bell MJ. SAT0534 Early Inflammatory Arthritis Detection using a Self-Administered Tool in a Canadian Francophone Population. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2013-eular.2258] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
17
|
Tavares R, Veinot P, Bell M. SAT0478 Early inflammatory arthritis detection using a self-administered tool versus general practitioner diagnosis in primary care. Ann Rheum Dis 2013. [DOI: 10.1136/annrheumdis-2012-eular.3424] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
18
|
Tavares R, Wells GA, Bykerk VP, Guillemin F, Tugwell P, Bell MJ. Validation of a Self-administered Inflammatory Arthritis Detection Tool for Rheumatology Triage. J Rheumatol 2013; 40:417-24. [DOI: 10.3899/jrheum.120096] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Objective.The benefits of early intensive treatment of inflammatory arthritis (IA) are dependent on timely and accurate case identification. In our study, a scoring algorithm for a self-administered IA detection tool was developed and validated for the rheumatology triage clinical setting.Methods.A total of 143 consecutive consenting adults, newly referred to 2 outpatient rheumatology practices, completed the tool. A scoring algorithm was derived from the best-fit logistic regression model using age, sex, and responses to the 12 tool items as candidate predictors of the rheumatologists' blinded classification of IA. Bootstrapping was used to internally validate and refine the model.Results.The 30 IA cases were younger than the 113 non-cases (p < 0.0001) and included clinical diagnoses of early IA (n = 10), rheumatoid arthritis (n = 9), and spondyloarthropathies (n = 11). Non-cases included osteoarthritis (n = 46), pain syndromes (n = 19), systemic lupus erythematosus (n = 5), and miscellaneous, noninflammatory musculoskeletal complaints (n = 43). The best-fit model included younger age, male sex, “trouble making a fist,” “morning stiffness,” “ever told you have RA,” and “psoriasis diagnosis.” The overall predictive performance (standard error, SE) of the derivation model was 0.91 (0.03). Internal validation of the derivation model across 200 bootstrap samples resulted in a mean predictive performance (SE) of 0.904 (0.002). The refined tool had a mean predictive performance (SE) of 0.915 (0.002), a sensitivity of 0.855 (0.005), and specificity of 0.873 (0.003).Conclusion.A simple, self-administered tool was developed and internally validated for the sensitive and specific detection of IA in a rheumatology waiting list sample. The tool may be used to triage IA from rheumatology referrals.
Collapse
|
19
|
Hu JCY, Seo BK, Neri QV, Rozenwaks Z, Palermo GD, Fields T, Neri QV, Monahan D, Rosenwaks Z, Palermo GD, Szkodziak P, Plewka K, Wozniak S, Czuczwar P, Mroczkowski A, Lorenzo Leon C, Hernandez J, Chinea Mendez E, Concepcion Lorenzo C, Sanabria Perez V, Puopolo M, Palumbo A, Toth B, Franz C, Montag M, Boing A, Strowitzki T, Nieuwland R, Griesinger G, Schultze-Mosgau A, Cordes T, Depenbusch M, Diedrich K, Vloeberghs V, Verheyen G, Camus M, Van de Velde H, Goossens A, Tournaye H, Coppola G, Di Caprio G, Wilding M, Ferraro P, Esposito G, Di Matteo L, Dale R, Coppola G, Dale B, Daoud S, Auger J, Wolf JP, Dulioust E, Lafuente R, Lopez G, Brassesco M, Hamad M, Montenarh M, Hammadeh M, Robles F, Magli MC, Crippa A, Pescatori E, Ferraretti AP, Gianaroli L, Zahiri M, Movahedin M, Mowla SJ, Noruzinia M, Crippa A, Ferraretti AP, Magli MC, Crivello AM, Robles F, Gianaroli L, Sermondade N, Dupont C, Hafhouf E, Cedrin-Durnerin I, Poncelet C, Benzacken B, Levy R, Sifer C, Ferfouri F, Boitrelle F, Clement P, Molina Gomes D, Bailly M, Selva J, Vialard F, Yaprak E, Basar M, Guzel E, Arda O, Irez T, Norambuena P, Krenkova P, Tuettelmann F, Kliesch S, Paulasova P, Stambergova A, Macek M, Macek M, Rivera R, Garrido-Gomez T, Galletero S, Meseguer M, Dominguez F, Garrido N, Mallidis C, Sanchez V, Weigeng L, Redmann K, Wistuba J, Gross P, Wuebbelling F, Fallnich C, Burger M, Kliesch S, Schlatt S, San Celestino Carchenilla M, Pacheco Castro A, Simon Sanjurjo P, Molinero Ballesteros A, Rubio Garcia S, Garcia Velasco JA, Macanovic B, Otasevic V, Korac A, Vucetic M, Garalejic E, Ivanovic Burmazovic I, Filipovic MR, Buzadzic B, Stancic A, Jankovic A, Velickovic K, Golic I, Markelic M, Korac B, Gosalvez J, Ruiz-Jorro M, Garcia-Ochoa C, Sachez-Martin P, Martinez-Moya M, Caballero P, Hasegawa N, Fukunaga N, Nagai R, Kitasaka H, Yoshimura T, Tamura F, Kato M, Nakayama K, Oono H, Kojima E, Yasue K, Watanabe H, Asano E, Hashiba Y, Asada Y, Das M, Al-Hathal N, San-Gabriel M, Phillips S, Kadoch IJ, Bissonnette F, Holzer H, Zini A, Zebitay AG, Irez T, Ocal P, Sahmay S, Karahuseyinoglu S, Usta T, Repping S, Silber S, Van Wely M, Datta A, Nayini K, Eapen A, Barlow S, Lockwood G, Tavares R, Baptista M, Publicover SJ, Ramalho-Santos J, Vaamonde D, Rodriguez I, Diaz A, Darr C, Chow V, Ma S, Smith R, Jeria F, Rivera J, Gabler F, Nicolai H, Cunha M, Viana P, Goncalves A, Silva J, Oliveira C, Teixeira da Silva J, Ferraz L, Madureira C, Doria S, Sousa M, Barros A, Herrero MB, Delbes G, Troueng E, Holzer H, Chan PTK, Vingris L, Setti AS, Braga DPAF, Figueira RCS, Iaconelli A, Borges E, Sargin Oruc A, Gulerman C, Zeyrek T, Yilmaz N, Tuzcuoglu D, Cicek N, Scarselli F, Terribile M, Franco G, Zavaglia D, Dente D, Zazzaro V, Riccio T, Minasi MG, Greco E, Cejudo-Roman A, Ravina CG, Candenas L, Gallardo-Castro M, Martin-Lozano D, Fernandez-Sanchez M, Pinto FM, Balasuriya A, Serhal P, Doshi A, Harper J, Romany L, Garrido N, Fernandez JL, Pellicer A, Meseguer M, Ribas-Maynou J, Garcia-Peiro A, Fernandez-Encinas A, Prada E, Jorda I, Cortes P, Llagostera M, Navarro J, Benet J, Kesici H, Cayli S, Erdemir F, Karaca Z, Aslan H, Karaca Z, Cayli S, Ocakli S, Kesici H, Erdemir F, Aslan H, Tas U, Ozdemir AA, Aktas RG, Tok OE, Ocakli S, Cayli S, Karaca Z, Erdemir F, Aslan H, Li S, Lu C, Hwu Y, Lee RK, Landaburu I, Gonzalvo MC, Clavero A, Ramirez JP, Pedrinaci S, Serrano M, Montero L, Carrillo S, Weiss J, Ortiz AP, Castilla JA, Sahin O, Bakircioglu E, Serdarogullari M, Bayram A, Yayla S, Ulug U, Tosun SB, Bahceci M, Aktas RG, Ozdemir AA, Tok OE, Yoon SY, Shin DH, Shin TE, Park EA, Won HJ, Kim YS, Lee WS, Yoon TK, Lee DR, Hattori H, Nakajo Y, Kyoya T, Kuchiki M, Kanto S, Kyono K, Park M, Park MR, Lim EJ, Lee WS, Yoon TK, Lee DR, Choi Y, Mitra A, Bhattacharya J, Kundu A, Mukhopadhaya D, Pal M, Enciso M, Alfarawati S, Wells D, Fernandez-Encinas A, Garcia-Peiro A, Ribas-Maynou J, Abad C, Amengual MJ, Navarro J, Benet J, Esmaeili V, Safiri M, Shahverdi AH, Alizadeh AR, Ebrahimi B, Brucculeri AM, Ruvolo G, Giovannelli L, Schillaci R, Cittadini E, Scaravelli G, Perino A, Cortes Gallego S, Gabriel Segovia A, Nunez Calonge R, Guijarro Ponce A, Ortega Lopez L, Caballero Peregrin P, Heindryckx B, Kashir J, Jones C, Mounce G, Ramadan WM, Lemmon B, De Sutter P, Parrington J, Turner K, Child T, McVeigh E, Coward K, Bakircioglu E, Ulug U, Tosun S, Serdarogullari M, Bayram A, Ciray N, Bahceci M, Saeidi S, Shapouri F, Hoseinifar H, Sabbaghian M, Pacey A, Aflatoonian R, Bosco L, Ruvolo G, Carrillo L, Pane A, Manno M, Roccheri MC, Cittadini E, Selles E, Garcia-Herrero S, Martinez JA, Munoz M, Meseguer M, Garrido N, Durmaz A, Dikmen N, Gunduz C, Tavmergen Goker E, Tavmergen E, Gozuacik D, Vatansever HS, Kara B, Calimlioglu N, Yasar P, Tavmergen E, Tavmergen Goker E, Semerci B, Baka M, Ozbilgin K, Karabulut A, Tekin A, Sabah B, Cottin V, Kottelat D, Fellmann M, Halm S, Rosenthaler E, Kisida T, Kojima F, Sakamoto T, Makutina VA, Balezin SL, Rosly OF, Slishkina TV, Hatzi E, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Zikopoulos K, Georgiou I, Zikopoulos K, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Hatzi E, Georgiou I, Georgiou I, Lazaros L, Xita N, Makrydimas G, Sofikitis N, Kaponis A, Stefos T, Hatzi E, Zikopoulos K, Hibi H, Ohori T, Sumitomo M, Asada Y, Anarte C, Calvo I, Domingo A, Presilla N, Aleman M, Bou R, Guardiola F, Agirregoikoa JA, De Pablo JL, Barrenetxea G, Zhylkova I, Feskov O, Feskova I, Zozulina O, Somova O, Nabi A, Khalili MA, Roudbari F, Parmegiani L, Cognigni GE, Bernardi S, Taraborrelli S, Troilo E, Ciampaglia W, Pocognoli P, Infante FE, Tabarelli de fatis C, Arnone A, Maccarini AM, Filicori M, Silva L, Oliveira JBA, Petersen CG, Mauri AL, Massaro FC, Cavagna M, Baruffi RLR, Franco JG, Fujii Y, Endou Y, Mtoyama H, Shokri S, Aitken RJ. ANDROLOGY. Hum Reprod 2012. [DOI: 10.1093/humrep/27.s2.73] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/13/2022] Open
|
20
|
Funke V, Bouzas L, Dulley F, Vigorito A, Moreira MC, Mauad M, Chiattone R, Salvador J, Hamerschlak N, Paton E, Gouveia R, Silla L, Coelho E, Teixeira G, Tavares R, Miranda E, Correa E, de Souza C, Matos M, Navarro G, Flowers M. A Survey of Chronic GVHD and Other Outcomes – a Snapshot of Brazilian Allogeneic Hematopoietic Cell Transplantation (HCT) Centers. Biol Blood Marrow Transplant 2011. [DOI: 10.1016/j.bbmt.2010.12.568] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
21
|
Tavares R, Wells GA, Scarf J, Cagaanan R, Bykerk VP, Bell MJ. Classification of rheumatologic opinion on early inflammatory arthritis: harmonization of a heterogeneous standard. Arthritis Care Res (Hoboken) 2010; 62:1407-14. [PMID: 20506530 DOI: 10.1002/acr.20250] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE Interrater variability limits rheumatologic opinion as a reference standard for early inflammatory arthritis (IA) classification. The study objectives were to determine whether rheumatologic opinion is associated with potential early IA classification methods despite high interrater variability, and to compare the relative strengths of those associations. METHODS Eighteen rheumatologists independently classified 30 initial rheumatology presentation summaries as early IA or not and recommended a pharmacotherapy. Case fulfillment of the following classification methods was independently determined: early referral to rheumatology recommendation for rheumatoid arthritis (ERRR), common early IA cohort inclusion criteria (CEAC), and prevalent IA classification criteria (American College of Rheumatology [ACR]/European Spondylarthropathy Study Group [ESSG]). Associations between rheumatologic opinion, disease-modifying antirheumatic drug (DMARD) recommendation, and each classification method were determined. RESULTS Participating rheumatologists published on early IA and represented 3 continents. The median case was age 43 (interquartile range [IQR] 30-53) years, had 40 (IQR 24-104) weeks of symptoms, 60 (IQR 18-120) minutes of morning stiffness, a swollen joint count of 6 (IQR 1-13), and an erythrocyte sedimentation rate of 25 (IQR 10-51) mm/hour. The mean ± SD multiple-rater kappa for rheumatologic opinion on early IA was 0.16 ± 0.02. The common odds ratios for associations between rheumatologic opinion and ERRR, CEAC, and ACR/ESSG were 10.3 (95% confidence interval [95% CI] 4.6-23.2), 4.4 (95% CI 2.5-7.7), and 0.7 (95% CI 0.4-1.1), respectively. Odds ratios for associations between DMARD recommendation and ERRR, rheumatologic opinion, CEAC, and ACR/ESSG were 18.7 (95% CI 8.1-43.2), 10.6 (95% CI 6.0-18.8), 2.8 (95% CI 1.7-4.6), and 0.5 (95% CI 0.3-0.7), respectively. CONCLUSION Classification methods can be used to harmonize rheumatologic opinion of early IA despite high interrater variability. The ERRR is very strongly associated with both rheumatologic opinions of early IA and DMARD treatment recommendations.
Collapse
|
22
|
e Silva MCM, De Brito AM, Tavares R, de Arajo JLC, De Lima Araujo A. Reveal the sexual abuse in children and adolescents: analysis of the invisibility of the problem on the epidemiological and clinical perspective, legal. Recife/Brazil. Inj Prev 2010. [DOI: 10.1136/ip.2010.029215.238] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
|
23
|
e Silva MCM, De Brito AM, Tavares R, de Arajo JLC, De Lima Araujo A. Reports of interpersonal violence on residents of Recife identified in the public health services. Inj Prev 2010. [DOI: 10.1136/ip.2010.029215.379] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
|
24
|
Bento DP, Tavares R, Baptista Leite R, Miranda A, Ramos S, Ventura F, Araújo C, Cunha AR, Matos AA, Mansinho K. Adult-Onset Still's Disease and cytomegalovirus infection. Acta Reumatol Port 2010; 35:259-263. [PMID: 20711100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/29/2023]
Abstract
We present a case of a previously asymptomatic 34-year-old man that presented to the emergency department with two weeks of fever, arthralgia of the wrists and knees and sore throat. He was diagnosed with cytomegalovirus (CMV) mononucleosis. The patient remained symptomatic in the 5 following months. After an extensive workup to exclude other clinical conditions, a liver biopsy was performed and CMV hepatitis was diagnosed. He started valganciclovir therapy. Approximately one year after the initial complaints, the patient remained ill and presented clinical criteria compatible with Adult Onset Still's Disease. The patient had a marked improvement after institution of prednisolone, an effect that has been sustained during the following months.
Collapse
Affiliation(s)
- Diogo Ponces Bento
- Department of Infectious Diseases and Tropical Medicine, Egas Moniz Hospital, Lisboa.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Bell MJ, Tavares R, Guillemin F, Bykerk VP, Tugwell P, Wells GA. Development of a self-administered early inflammatory arthritis detection tool. BMC Musculoskelet Disord 2010; 11:50. [PMID: 20236522 PMCID: PMC2851668 DOI: 10.1186/1471-2474-11-50] [Citation(s) in RCA: 26] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 10/05/2009] [Accepted: 03/17/2010] [Indexed: 11/10/2022] Open
Abstract
BACKGROUND Barriers to care limit the potential benefits of pharmacological intervention for inflammatory arthritis. A self-administered questionnaire for early inflammatory arthritis (EIA) detection may complement contemporary triage interventions to further reduce delays to rheumatologic care. The objective of this study was to develop a self-administered EIA detection tool for implementation in pre-primary care settings. METHODS A core set of dimensions and constructs for EIA detection were systematically derived from the literature and augmented by investigative team arbitration. Identified constructs were formulated into lay language questions suitable for self-administration. A three-round Delphi consensus panel of EIA experts and stakeholders evaluated the relevance of each question to EIA detection and suggested additional items. Questions accepted by less than 70% of respondents in rounds one or two were eliminated. In round three, questions accepted by at least 80% of the panel were selected for the tool. RESULTS Of 584 citations identified, data were extracted from 47 eligible articles. Upon arbitration of the literature synthesis, 30 constructs encompassing 13 dimensions were formulated into lay language questions and posed to the Delphi panel. A total of 181 EIA experts and stakeholders participated on the Delphi panel: round one, 60; round two, 59; and, round three, 169; 48 participated in all three rounds. The panel evaluated the 30 questions derived from the literature synthesis, suggested five additional items, and eliminated a total of 24. The eleven-question instrument developed captured dimensions of articular pain, swelling, and stiffness, distribution of joint involvement, function, and diagnostic and family history. CONCLUSIONS An eleven-question, EIA detection tool suitable for self-administration was developed to screen subjects with six to 52 weeks of musculoskeletal complaints. Psychometric and performance property testing of the tool is ongoing.
Collapse
Affiliation(s)
- Mary J Bell
- Division of Rheumatology, Department of Medicine, University of Toronto, Sunnybrook Health Sciences Centre, Toronto, Canada.
| | | | | | | | | | | |
Collapse
|
26
|
Bento D, Leite R, Tavares R, MIranda A, Ventura F, Araújo C, Mansinho K. CMV infection causing Adult Onset Still's Disease: A clinical case. Int J Infect Dis 2010. [DOI: 10.1016/j.ijid.2010.02.376] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
27
|
Hausherr A, Tavares R, Schäffer M, Obermeier A, Miksch C, Mitina O, Ellwart J, Hallek M, Krause G. Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases. Oncogene 2007; 26:4987-98. [PMID: 17310994 DOI: 10.1038/sj.onc.1210306] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
An acidic domain (AD) of gp130 was previously found to interact with the Src family kinase (SFK) Hck. Here, the influence of myristoylated peptides derived from this AD was assessed in the mouse myeloma cell line, 7TD1. The IL-6-dependent growth of 7TD1 cells was reduced by approximately 75%, if 100 microM of myristoylated 18mer peptide (18AD) was included in the growth medium, but was unaffected by a control peptide with scrambled sequence (18sc). A similar differential inhibition by peptides 18AD and 18sc was observed for the erythropoietin-dependent growth of BaF-EH cells expressing chimeric erythropoietin receptor-gp130 and human Hck and for the human myeloma cell line INA-6. While the peptide 18AD concentration inhibiting 50% was approximately 30 microM in 7TD1 and BaF-EH cells, peptide 18AD did not significantly inhibit growth of IL-6-independent MM1.S myeloma and OKT1 hybridoma cells or of BaF-EH cells supplied with IL-3. Treatment with 100 microM peptide 18AD caused the same degree or 60% of apoptosis induction as IL-6 deprivation in 7TD1 or INA-6 cells, respectively. Co-immunoprecipitation experiments revealed that peptide 18AD interfered with the association of Hck and gp130 in 7TD1 lysates in a concentration-dependent manner. IL-6-treatment of INA-6 cells induced the kinase activities of Fyn, Lyn and Hck, but not Src, and the IL-6-induced SFK activities were inhibited by peptide 18AD. Expression in 7TD1 cells of a kinase-inactive Hck mutant (K269R) elicited a dominant-negative effect on cell number increases providing further evidence that SFKs are required for gp130 signalling in myeloma cells.
Collapse
Affiliation(s)
- A Hausherr
- Clinical Cooperation Group Gene Therapy, GSF National Research Center for Environment and Health, Munich, Germany
| | | | | | | | | | | | | | | | | |
Collapse
|
28
|
Falcão LFD, de Melo RMV, Guimarães HP, Gazoni F, Lima RC, Miranda DB, Tavares R, Lopes AC. Implementation of evidence in clinical practice for prevention of thromboembolic events in intensive medicine. Crit Care 2007. [PMCID: PMC3301166 DOI: 10.1186/cc5826] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022] Open
|
29
|
Resnick MB, Sabo E, Meitner PA, Kim SS, Cho Y, Kim HK, Tavares R, Moss SF. Global analysis of the human gastric epithelial transcriptome altered by Helicobacter pylori eradication in vivo. Gut 2006; 55:1717-24. [PMID: 16641130 PMCID: PMC1856477 DOI: 10.1136/gut.2006.095646] [Citation(s) in RCA: 60] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 01/08/2023]
Abstract
OBJECTIVE The transcriptional profile of gastric epithelial cell lines cocultured with Helicobacter pylori and the global gene expression of whole gastric mucosa has been described previously. We aimed to overcome limitations of previous studies by determining the effects of H pylori eradication on the transcriptome of purified human gastric epithelium using each patient as their own control. DESIGN Laser capture microdissection (LCM) was used to extract mRNA from paraffin-embedded antral epithelium from 10 patients with peptic ulcer disease, before and after H pylori eradication. mRNA was reverse transcribed and applied on to Affymetrix cDNA microarray chips customised for formalin-fixed tissue. Differentially expressed genes were identified and a subset validated by real-time polymerase chain reaction (PCR). RESULTS A total of 13 817 transcripts decreased and 9680 increased after H pylori eradication. Applying cut-off criteria (p<0.02, fold-change threshold 2.5) reduced the sample to 98 differentially expressed genes. Genes detected included those previously implicated in H pylori pathophysiology such as interleukin 8, chemokine ligand 3, beta defensin and somatostatin, as well as novel genes such as GDDR (TFIZ1), chemokine receptors 7 and 8, and gastrokine. CONCLUSIONS LCM of archival specimens has enabled the identification of gastric epithelial genes whose expression is considerably altered after H pylori eradication. This study has confirmed the presence of genes previously implicated in the pathogenesis of H pylori, as well as highlighted novel candidates for further investigation.
Collapse
Affiliation(s)
- M B Resnick
- Department of Pathology, Rhode Island Hospital, 593 Eddy Street, Providence, RI 02903, USA.
| | | | | | | | | | | | | | | |
Collapse
|
30
|
Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 2006; 28:977-86. [PMID: 16782234 DOI: 10.1016/j.neurobiolaging.2006.05.016] [Citation(s) in RCA: 334] [Impact Index Per Article: 18.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/08/2005] [Revised: 04/07/2006] [Accepted: 05/09/2006] [Indexed: 02/02/2023]
Abstract
Thinning and discontinuities within the vascular basement membrane (VBM) are associated with leakage of the plasma protein prothrombin across the blood-brain barrier (BBB) in Alzheimer's disease (AD). Prothrombin immunohistochemistry and ELISA assays were performed on prefrontal cortex. In severe AD, prothrombin was localized within the wall and neuropil surrounding microvessels. Factor VIII staining in severe AD patients indicated that prothrombin leakage was associated with shrinkage of endothelial cells. ELISA revealed elevated prothrombin levels in prefrontal cortex AD cases that increased with the Braak stage (Control=1.39, I-II=1.76, III-IV=2.28, and V-VI=3.11 ng prothrombin/mg total protein). Comparing these four groups, there was a significant difference between control and Braak V-VI (p=0.0095) and also between Braak stages I-II and V-VI (p=0.0048). There was no significant difference in mean prothrombin levels when cases with versus without cerebral amyloid angiopathy (CAA) were compared (p-value=0.3627). When comparing AD patients by APOE genotype (ApoE3,3=2.00, ApoE3,4=2.49, and ApoE4,4=2.96 ng prothrombin/mg total protein) an analysis of variance indicated a difference between genotypes at the 10% significance level (p=0.0705). Tukey's test indicated a difference between the 3,3 and 4,4 groups (p=0.0607). These studies provide evidence that in advanced AD (Braak stage V-VI), plasma proteins like prothrombin can be found within the microvessel wall and surrounding neuropil, and that leakage of the blood-brain barrier may be more common in patients with at least one APOE4 allele.
Collapse
Affiliation(s)
- B D Zipser
- Department of Pathology (Neuropathology Division), Brown Medical School, Rhode Island Hospital, Providence, RI 02903, United States
| | | | | | | | | | | | | | | | | |
Collapse
|
31
|
Bagatin E, Neder JA, Nery LE, Terra-Filho M, Kavakama J, Castelo A, Capelozzi V, Sette A, Kitamura S, Favero M, Moreira-Filho DC, Tavares R, Peres C, Becklake MR. Non-malignant consequences of decreasing asbestos exposure in the Brazil chrysotile mines and mills. Occup Environ Med 2005; 62:381-9. [PMID: 15901885 DOI: 10.1136/oem.2004.016188] [Citation(s) in RCA: 17] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
AIMS To investigate the consequences of improvement in the workplace environment over six decades (1940-96) in asbestos miners and millers from a developing country (Brazil). METHODS A total of 3634 Brazilian workers with at least one year of exposure completed a respiratory symptoms questionnaire, chest radiography, and a spirometric evaluation. The study population was separated into three groups whose working conditions improved over time: group I (1940-66, n = 180), group II (1967-76, n = 1317), and group III (1977-96, n = 2137). RESULTS Respiratory symptoms were significantly related to spirometric abnormalities, smoking, and latency time. Breathlessness, in particular, was also associated with age, pleural abnormality and increased cumulative exposure to asbestos fibres. The odds ratios (OR) for parenchymal and/or non-malignant pleural disease were significantly lower in groups II and III compared to group I subjects (0.29 (0.12-0.69) and 0.19 (0.08-0.45), respectively), independent of age and smoking status. Similar results were found when groups were compared at equivalent latency times (groups I v II: 30-45 years; groups II v III: 20-25 years). Ageing, dyspnoea, past and current smoking, and radiographic abnormalities were associated with ventilatory impairment. Lower spirometric values were found in groups I and II compared to group III: lung function values were also lower in higher quartiles of latency and of cumulative exposure in these subjects. CONCLUSIONS Progressive improvement in occupational hygiene in a developing country is likely to reduce the risk of non-malignant consequences of dust inhalation in asbestos miners and millers.
Collapse
Affiliation(s)
- E Bagatin
- Area of Occupational Health, State University of Campinas (UNICAMP), Campinas, SP, Brazil.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
32
|
Richelle-Maurer E, De Kluijver M, Feio S, Gaudêncio S, Gaspar H, Gomez R, Tavares R, Van de Vyver G, Van Soest R. Localization and ecological significance of oroidin and sceptrin in the Caribbean sponge Agelas conifera. BIOCHEM SYST ECOL 2003. [DOI: 10.1016/s0305-1978(03)00072-3] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
33
|
Terra-Filho M, Kavakama J, Bagatin E, Capelozzi VL, Nery LE, Tavares R. Identification of rounded atelectasis in workers exposed to asbestos by contrast helical computed tomography. Braz J Med Biol Res 2003; 36:1341-7. [PMID: 14502366 DOI: 10.1590/s0100-879x2003001000010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Rounded atelectasis (RA) is a benign and unusual form of subpleural lung collapse that has been described mostly in asbestos-exposed workers. This form of atelectasis manifests as a lung nodule and can be confused with bronchogenic carcinoma upon conventional radiologic examination. The objective of the present study was to evaluate the variation in contrast uptake in computed tomography for the identification of asbestos-related RA in Brazil. Between January 1998 and December 2000, high-resolution computed tomography (HRCT) was performed in 1658 asbestos-exposed workers. The diagnosis was made in nine patients based on a history of prior asbestos exposure, the presence of characteristic (HRCT) findings and lesions unchanged in size over 2 years or more. In three of them the diagnosis was confirmed during surgery. The dynamic contrast enhancement study was modified to evaluate nodules and pulmonary masses. All nine patients with RA received iodide contrast according to weight. The average enhancement after iodide contrast was infused, reported as Hounsfield units (HU), increased from 62.5+/-9.7 to 125.4+/-20.7 (P < 0.05), with a mean enhancement of 62.5+/-19.7 (range 40 to 89) and with a uniform dense opacification. In conclusion, in this study all patients with RA showed contrast enhancement with uniform dense opacification. The main clinical implication of this finding is that this procedure does not permit differentiation between RA and malignant pulmonary neoplasm.
Collapse
Affiliation(s)
- M Terra-Filho
- Grupo Interinstitucional de Estudos de Doenças Relacionadas ao Amianto do Estado de São Paulo, Brasil
| | | | | | | | | | | |
Collapse
|
34
|
Halfoun VLRC, Pires MLE, Fernandes TJ, Victer F, Rodrigues KK, Tavares R. Videocapillaroscopy and Diabetes mellitus: area of transverse segment in nailfold capillar loops reflects vascular reactivity. Diabetes Res Clin Pract 2003; 61:155-60. [PMID: 12965104 DOI: 10.1016/s0168-8227(03)00111-6] [Citation(s) in RCA: 22] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
UNLABELLED The value of measuring projected area of transverse segment of hand nailfold capillary loops using computerized videophotometry was studied in 17 healthy individuals (10 women and 7 men) group A and 17 patients with diabetes type 2 (10 women and 7 men) group B with comparable ages (49.94+/-8.62 x 49.11+/-14.63 years old P=0.49). Videocapillaroscopy (VC) was performed under controlled temperature environment (24-26 degrees C). The test of post-occlusive reactive hyperemia was performed using a sphygmomanometer attached to the fourth left hand finger, 20 mmHg above maximum arterial pressure during 1 min. Images were captured each 2 s during 1 min. Time averages to reach the maximum post-ischemia area were determined as well as the area's increment percent in both groups. Both averages were compared by the Mann-Whitney test. There was no differences between area increments percent averages among controls and patients with diabetes (52.49+/-22.6 x 67.99+/-47.48% P=0.67), but the time to reach it during reperfusion was significantly increased among diabetics (5.52+/-2.96 x 18.58+/-8.08 s P<0.0001). CONCLUSIONS changes of capillary response to ischemia may be observed among patients with diabetes through bi-dimensional measures of projected area of capillary loops transverse segment in VC using a computerized system of image analysis. Patients with Diabetes mellitus do not have significantly different maximum area increments than controls, but spend more time to reach it during reperfusion.
Collapse
Affiliation(s)
- V L R C Halfoun
- Faculdade de Medicina and Hospital Universitário Clementino Fraga Filho Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil
| | | | | | | | | | | |
Collapse
|
35
|
Faleiro ML, Miguel MG, Ladeiro F, Venâncio F, Tavares R, Brito JC, Figueiredo AC, Barroso JG, Pedro LG. Antimicrobial activity of essential oils isolated from Portuguese endemic species of Thymus. Lett Appl Microbiol 2003; 36:35-40. [PMID: 12485339 DOI: 10.1046/j.1472-765x.2003.01259.x] [Citation(s) in RCA: 121] [Impact Index Per Article: 5.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
AIMS Thymus species are wild species mostly found in the arid lands of Portugal. Possible antimicrobial properties of Thymus essential oils have been investigated. The chemical composition of the essential oils and the antimicrobial activity of Thymus mastichina (L) L. subsp. mastichina, T. camphoratus and T. lotocephalus from different regions of Portugal were analysed. METHODS AND RESULTS Hydrodistillation was used to isolate the essential oils and the chemical analyses were performed by gas chromatography (GC) and GC coupled to mass spectrometry. The antimicrobial activity was tested by the disc agar diffusion technique against Candida albicans, Escherichia coli, Listeria monocytogenes, Proteus mirabilis, Salmonella spp. and Staphylococcus aureus. Pure linalool, 1,8-cineole and a mixture (1 : 1) of these compounds were included. Linalool, 1,8-cineole or linalool/1,8-cineole and linalool/1,8-cineole/linalyl acetate were the major components of the essential oils, depending on the species or sampling place. The essential oils isolated from the Thymus species studied demonstrated antimicrobial activity but the micro-organisms tested had significantly different sensitivities. CONCLUSIONS The antimicrobial activity of essential oils may be related to more than one component. SIGNIFICANCE AND IMPACT OF THE STUDY Portuguese endemic species of Thymus can be used for essential oil production for food spoilage control, cosmetics and pharmaceutical use. Further studies will be required to elucidate the cell targets of the essential oil components.
Collapse
Affiliation(s)
- M L Faleiro
- Faculdade de Engenharia de Recursos Naturais, Universidade do Algarve, Faro and INETI, IBQTA, Departamento de Tecnologia das Indústrias Químicas, Lisboa and Centro de Biotecnologia Vegetal, FCL, Lisboa, Portugal.
| | | | | | | | | | | | | | | | | |
Collapse
|
36
|
Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S, Hovanesian V, Fallon J, Kuo-Leblanc V, Glass D, Hulette C, Rosenberg C, Vitek M, Stopa E. Corrigendum to “Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease” [J. Neurol. Sci. 203–204 (2002) 183–187]. J Neurol Sci 2003. [DOI: 10.1016/s0022-510x(02)00437-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
|
37
|
Salloway S, Gur T, Berzin T, Tavares R, Zipser B, Correia S, Hovanesian V, Fallon J, Kuo-Leblanc V, Glass D, Hulette C, Rosenberg C, Vitek M, Stopa E. Effect of APOE genotype on microvascular basement membrane in Alzheimer's disease. J Neurol Sci 2002; 203-204:183-7. [PMID: 12417381 DOI: 10.1016/s0022-510x(02)00288-5] [Citation(s) in RCA: 70] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
APOE4 homozygosity has been associated with an increased risk of sporadic Alzheimer's disease through a mechanism, which has yet to be defined. Recent evidence has suggested that microvascular basement membrane injury may be a critical factor in the pathogenesis of AD-related dementia. In previous studies, we have shown that the synaptic organizing protein agrin can be found in neurons, and is a major component of the brain microvascular basement membrane. Here, we compare the basement membrane surface area of cortical microvasculature in AD brains by staining with an anti-agrin antibody. Quantitative morphometric analysis was used to determine the mean basement area (micro(2)) of prefrontal cortical microvessels. An average of 10 capillaries was measured in each of 35 cases of AD genotyped for APOE status. APOE4,4 homozygotes had smaller capillary basement membrane areas (17.4 micro(2))+/-6.2) than APOE3,3 homozygotes (26.9 micro(2)+/-6.5), p<0.001. The capillary basement membrane areas (CBMA) of heterozygotes APOE3,4 did not differ significantly from APOE3,3 or APOE4,4. Braak stage did not contribute significantly to CBMA. However, a preliminary analysis suggests an interaction between APOE4,4 and Braak V-VI producing smaller CBMA, a finding which needs to be confirmed with a larger sample. These data support the hypothesis that APOE4,4 is associated with thinning of the microvascular basement membrane in Alzheimer's disease.
Collapse
Affiliation(s)
- S Salloway
- Brown Medical School, Providence, RI, USA.
| | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
38
|
Tavares R, Vidal J, van Lammeren A, Kreis M. AtSKtheta, a plant homologue of SGG/GSK-3 marks developing tissues in Arabidopsis thaliana. Plant Mol Biol 2002; 50:261-71. [PMID: 12175018 DOI: 10.1023/a:1016009831678] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/20/2023]
Abstract
The Arabidopsis thaliana AtSK sub-family of serine threonine protein kinases groups 10 homologues of SHAGGY/GSK-3. Previous results obtained with different plant members of the SHAGGY/GSK-3 family strongly suggest that these proteins are involved in cell differentiation and stress responses. In order to gain further insight into the biological functions of this family in A. thaliana, polyclonal antibodies were raised against specific domains of the AtSKtheta protein. The antibodies were purified and used in immunolocalization studies in various tissues of A. thaliana. Our results show that the protein is located in the cell nuclei of various developing organs. Differential protein localization profiles were found in some of the observed tissues, notably during gametophyte and embryo development. Based on this protein location pattern, and on what is known about the mammalian members of the GSK-3 family, we suggest that AtSKtheta may have a role in the regulation of transcription factors.
Collapse
Affiliation(s)
- R Tavares
- Institut de Biotechnologie des Plantes (IBP), Laboratoire de Biologie du Développement des Plantes, Université de Paris-Sud, UMR CNRS 8618, 91405 Orsay, France
| | | | | | | |
Collapse
|
39
|
Hidalgo MP, Camozzato A, Cardoso L, Preussler C, Nunes CE, Tavares R, Posser MS, Chaves MLF. Evaluation of behavioral states among morning and evening active healthy individuals. Braz J Med Biol Res 2002; 35:837-42. [PMID: 12131925 DOI: 10.1590/s0100-879x2002000700012] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
The Horne-Ostberg questionnaire partly covers some factors that may be important determinants of peak time and characterize patterns of behavior. We conducted a study for the evaluation of self-reported behavioral states (hunger sensation, availability for study, physical exercise, solving daily problems, and time preferences) as expressions of underlying cyclic activity. Three hundred and eighteen community subjects without history of medical, psychiatric, or sleep disorders were evaluated in a cross-sectional design. A self-report about daily highest level of activity was used to categorize individuals into morning, evening, and indifferently active. Time-related behavioral states were evaluated with 23 visual analog questions. The responses to most analogic questions were significantly different between morning and evening active subjects. Logistic regression analysis identified a group of behaviors more strongly associated with the self-reported activity pattern (common wake up time, highest subjective fatigue, as well as wake up, bedtime, exercise and study preferences). These findings suggested that the patterns of activity presented by normal adults were related to specific common behavioral characteristics that may contribute to peak time.
Collapse
Affiliation(s)
- M P Hidalgo
- Curso de Pós-Graduação de Medicina Interna, Faculdade de Medicina, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brasil
| | | | | | | | | | | | | | | |
Collapse
|
40
|
|
41
|
Schaeffer M, Schneiderbauer M, Weidler S, Tavares R, Warmuth M, de Vos G, Hallek M. Signaling through a novel domain of gp130 mediates cell proliferation and activation of Hck and Erk kinases. Mol Cell Biol 2001; 21:8068-81. [PMID: 11689697 PMCID: PMC99973 DOI: 10.1128/mcb.21.23.8068-8081.2001] [Citation(s) in RCA: 48] [Impact Index Per Article: 2.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2001] [Accepted: 08/16/2001] [Indexed: 01/30/2023] Open
Abstract
Interleukin-6 (IL-6) induces the activation of the Src family kinase Hck, which is associated with the IL-6 receptor beta-chain, gp130. Here we describe the identification of an "acidic" domain comprising amino acids 771 to 811 of gp130 as a binding region for Hck, which mediates proliferative signaling. The deletion of this region of gp130 (i.e., in deletion mutant d771-811) resulted in a significant reduction of Hck kinase activity and cell proliferation upon stimulation of gp130 compared to wild-type gp130. In addition, d771-811 disrupted the growth factor-stimulated activation of Erk and the dephosphorylation of Pyk2. Based on these findings, we propose a novel, acidic domain of gp130, which is responsible for the activation of Hck, Erk, and Pyk2 and signals cell proliferation upon growth factor stimulation.
Collapse
Affiliation(s)
- M Schaeffer
- Medizinische Klinik III, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, and Klinische Kooperationsgruppe Gentherapie, National Research Center for Health and Environment (GSF), D-81377 Munich, Germany
| | | | | | | | | | | | | |
Collapse
|
42
|
Moiteiro C, Justino F, Tavares R, Marcelo-Curto MJ, Florêncio MH, Nascimento MS, Pedro M, Cerqueira F, Pinto MM. Synthetic secofriedelane and friedelane derivatives as inhibitors of human lymphocyte proliferation and growth of human cancer cell lines in vitro. J Nat Prod 2001; 64:1273-1277. [PMID: 11678649 DOI: 10.1021/np010217m] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Controlled silylation of friedelin (1) from cork smoker wash solids, a byproduct generated during processing of corkboard by steam baking, gave 3-trimethylsiloxyfriedel-2-ene (3) in high yields. Oxidation of 3 with OsO(4)/NMMO produced 2alpha-hydroxyfriedelan-3-one (cerin) (5), from which the new 2,3-secofriedelan-2-al-3-oic acid (6) was obtained quantitatively by periodic acid oxidation. Oxidation of 3 with DDQ afforded friedel-1-en-3-one (8). Reductive ozonolysis of 3 gave 2alpha,3beta-dihydroxyfriedelane, pachysandiol A (7). Compound 6 proved to be a potent inhibitor of human lymphocyte proliferation (IC(50) = 10.7 microM) and of the growth of a human cancer cell line (GI(50) = 5.4-17.2 microM). (13)C NMR data for compounds (3, 4, 5, 6a,7, and 8) are described for the first time.
Collapse
Affiliation(s)
- C Moiteiro
- INETI-Instituto Nacional de Engenharia e Tecnologia Industrial, Departamento de Tecnologia de Indústrias Químicas, Serviço de Química Fina, Estrada do Paço do Lumiar, 1649-038 Lisbon, Portugal.
| | | | | | | | | | | | | | | | | |
Collapse
|
43
|
de Lima M, Bonamino M, Vasconcelos Z, Colares M, Diamond H, Zalcberg I, Tavares R, Lerner D, Byington R, Bouzas L, da Matta J, Andrade C, Carvalho L, Pires V, Barone B, Maciel C, Tabak D. Prophylactic donor lymphocyte infusions after moderately ablative chemotherapy and stem cell transplantation for hematological malignancies: high remission rate among poor prognosis patients at the expense of graft-versus-host disease. Bone Marrow Transplant 2001; 27:73-8. [PMID: 11244440 DOI: 10.1038/sj.bmt.1702726] [Citation(s) in RCA: 80] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
We investigated the use of 'prophylactic' donor lymphocyte infusions (DLI) containing 1 x 107 CD3+ cells, given at 30, 60 and 90 days post-allogeneic blood and marrow transplantation (BMT), following conditioning with fludarabine 30 mg/m(2)/4 days and melphalan 70 mg/m(2)/2 days. GVHD prophylaxis consisted of cyclosporin A (CsA) 2 mg/kg daily with early tapering by day 60. Our goals were the rapid achievement of chimerism and disease control, providing an immunological platform for DLIs to treat refractory patients with hematological malignancies. Twelve heavily pre-treated patients with life expectancy less than 6 months were studied; none were in remission. Diagnoses were AML (n = 4), MDS (n = 1), ALL (n = 3), CML (n = 3) and multiple myeloma (n = 1). Response rate was 75%. Three patients are alive at a median of 450 days (range, 450-540). Two patients are in remission of CML in blast crisis and AML for more than 14 months. Median survival is 116 days (range, 25-648). Six patients received 12 DLIs; three patients developed acute GVHD after the first infusion and were excluded from further DLIs, but no GVHD occurred among patients receiving subsequent DLIs. One patient with CML in blast crisis went into CR after the first DLI. The overall incidence of acute GVHD was 70%. Primary causes of death were infections (n = 3), acute GVHD (n = 3), chronic GVHD (n = 1) and disease relapse (n = 2). We observed high response and chimerism rates at the expense of an excessive incidence of GVHD. DLI given at day +30 post BMT caused GVHD in 50% of the patients, and its role in this setting remains unclear.
Collapse
Affiliation(s)
- M de Lima
- Bone Marrow Transplantation Unit, Instituto Nacional de Cancer, Rio de Janeiro, Brazil
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
44
|
Tavares R, Aubourg S, Lecharny A, Kreis M. Organization and structural evolution of four multigene families in Arabidopsis thaliana: AtLCAD, AtLGT, AtMYST and AtHD-GL2. Plant Mol Biol 2000; 42:703-717. [PMID: 10809443 DOI: 10.1023/a:1006368316413] [Citation(s) in RCA: 27] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
The Arabidopsis Genome Initiative has released up to now more than 80% of the genome sequence of Arabidopsis thaliana. About 70% of the identified genes have at least one paralogue. In order to understand the biological function of individual genes, it is essential to study the structure, expression and organization of the entire multigene family. A systematic analysis of multigene families, made possible by the amount of genomic sequence data available, provides important clues for the understanding of genome evolution and plasticity. In this paper, four multigene families of A. thaliana are characterized, namely LCAD, HD-GL2, LGT and MYST. Members of HD-GL2 and LCAD have already been reported in plants. The LGT genes specify proteins containing motifs of glycosyl transferase. No plant genes similar to the LGT genes have been reported to date. The novel MYST family, most likely plant-specific, encodes proteins with no identified function. Sequencing and in silico analysis led to the characterization of 29 novel genes belonging to these four gene families. The organization, structure and evolution of all the members of the four families are discussed, as well as their chromosome location. Expression data of some of the paralogues of each family are also presented.
Collapse
Affiliation(s)
- R Tavares
- Institut de Biotechnologie des Plantes, Laboratoire de Biologie du Développement des Plantes, Université de Paris-Sud, Orsay France
| | | | | | | |
Collapse
|
45
|
Braekman JC, Daloze D, Tavares R, Hajdu E, Van Soest RW. Novel polycyclic guanidine alkaloids from two marine sponges of the genus Monanchora. J Nat Prod 2000; 63:193-196. [PMID: 10691707 DOI: 10.1021/np990403g] [Citation(s) in RCA: 55] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/23/2023]
Abstract
Two marine sponges of the genus Monanchora (Poecilosclerida, Crambeidae) have been found to contain new polycyclic guanidine alkaloids bearing the (5,6,8b)-triazaperhydroacenaphthylene skeleton. Their structures have been determined by detailed spectroscopic analysis. Dehydrobatzelladine C (1) has been isolated from M. arbuscula and crambescidins 359 (2) and 431 (3) from M. unguiculata. The chemotaxonomic implications of these findings are discussed.
Collapse
Affiliation(s)
- J C Braekman
- Laboratory of Bio-organic Chemistry, Department of Organic Chemistry, Faculty of Sciences, CP160/07, University of Brussels, 50 Avenue F. Roosevelt, 1050 Brussels, Belgium.
| | | | | | | | | |
Collapse
|
46
|
Tichtinsky G, Tavares R, Takvorian A, Schwebel-Dugué N, Twell D, Kreis M. An evolutionary conserved group of plant GSK-3/shaggy-like protein kinase genes preferentially expressed in developing pollen. Biochim Biophys Acta 1998; 1442:261-73. [PMID: 9804971 DOI: 10.1016/s0167-4781(98)00187-0] [Citation(s) in RCA: 34] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Genes and cDNAs encoding plant protein kinases highly homologous to the animal GSK-3/shaggy subfamily were isolated from Arabidopsis thaliana, Brassica napus, Petunia hybrida and Nicotiana tabacum using the P. hybrida PSK6 GSK-3/shaggy related cDNA as a probe. All the derived protein sequences contained the characteristic catalytic domain of GSK-3/shaggy protein kinases. Sequence comparisons within the catalytic domain with other plant GSK-3/shaggy like kinases clearly indicate that the novel sequences form an isolated group of genes termed the PSK6 group. All the proteins within this group possess an amino-terminal extension which contains short amino acid motifs highly conserved between species and possibly implicated in mitochondrial targeting. Northern hybridisation experiments and reverse transcriptase PCR analysis demonstrated that these novel cDNAs are predominantly expressed in developing pollen. The three genes isolated from P. hybrida and A. thaliana show the same genomic organisation into 12 introns and 13 exons. Although the size of the introns varies, their positions are conserved between genes and species. The comparison of these gene structures and the analysis of deduced protein sequences belonging to different plants hold important information to understand the function of individual members. They suggest that some of the characterised sequences represent most likely true orthologues whereas others must be paralogues. They also allow us to discuss the evolution of the plant GSK-3/shaggy like gene family with regard to plant speciation.
Collapse
Affiliation(s)
- G Tichtinsky
- Institut de Biotechnologie des Plantes, Laboratoire de Biologie du Développement des Plantes, Bâtiment 630, Université de Paris-Sud CNRS/ERS 569, F-91405 Orsay Cedex, France
| | | | | | | | | | | |
Collapse
|
47
|
Tavares R, Borba H, Monteiro M, Proença MJ, Lynce N, Rueff J, Bailey E, Sweetman GM, Lawrence RM, Farmer PB. Monitoring of exposure to acrylonitrile by determination of N-(2-cyanoethyl)valine at the N-terminal position of haemoglobin. Carcinogenesis 1996; 17:2655-60. [PMID: 9006103 DOI: 10.1093/carcin/17.12.2655] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023] Open
Abstract
A selected ion monitoring gas chromatography-mass spectrometry (GC-MS) procedure was developed to determine the interaction product formed by acrylonitrile (ACN) with the N-terminal amino group in haemoglobin. The product, N-(2-cyanoethyl)valine (CEV), was analysed following its release from the protein by a modified Edman degradation procedure. Quantitation was achieved using N-(2-cyanoethyl)-[2H8]Val-Leu-Ser as internal standard. The limit of detection of the assay was 1 pmol CEV/g globin. A close to linear dose-response relationship was found for adduct formation in rats treated with ACN by gavage. On the basis of a linear extrapolation, a dose of 1 mg/kg body wt yielded 248 pmol CEV/g globin. Two groups of workers who were exposed to ACN contained 1984 +/- SD 2066 (n = 9) and 2276 +/- SD 1338 (n = 7) pmol CEV/g globin respectively. These values were highly significantly greater (P < 0.01 following a one-way analysis of variance with a logarithmic transformation of the data) than those in a group of control workers in the same factory (31.1 +/- SD 18.5 pmol CEV/g globin, n = 11). The concentrations of N-terminal CEV in globin samples from 13 smoking and 10 non-smoking mothers and from their newborns were determined. Adduct levels in the smokers averaged 217 +/- 85.1 pmol CEV/g globin, significantly higher than the levels in non-smokers, which were undetectable. Individual values in the mothers were very highly correlated with the levels in their babies (which averaged 99.5 +/- 53.8 pmol CEV/g globin), which demonstrates that transplacental transfer of ACN occurs. Significant correlations were also found between the number of cigarettes smoked per day by the mother and the CEV levels in both the mothers' and newborns' globin. There was, however, no correlation between the CEV levels and those of the ethylene oxide adduct N-(2-hydroxyethyl)valine in samples from either the mothers or babies.
Collapse
Affiliation(s)
- R Tavares
- MRC Toxicology Unit, University of Leicester, UK
| | | | | | | | | | | | | | | | | | | |
Collapse
|
48
|
Lawrence RM, Sweetman GM, Tavares R, Farmer PB. Synthesis and characterization of peptide adducts for use in monitoring human exposure to acrylonitrile and ethylene oxide. Teratog Carcinog Mutagen 1996; 16:139-48. [PMID: 8983117 DOI: 10.1002/(sici)1520-6866(1996)16:3<139::aid-tcm1>3.0.co;2-j] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
Human exposure to ethylene oxide and acrylonitrile may be monitored by determination of the products that these electrophilic compounds form with the amino terminal of hemoglobin. The procedure involves a modified Edman degradation, using the reagent pentafluorophenyl isothiocyanate, which cleaves the adducted N-terminal amino acid from the protein chain as a substituted pentafluorophenyl thiohydantoin. This may then be quantitated using selected ion monitoring gas chromatography-mass spectrometry (GC-MS). To overcome problems arising from the lack of an ideal internal standard for this analysis, we have now synthesized adducts of ethylene oxide and acrylonitrile with the N-terminal tripeptide of the alpha-chain of human globin (Val-Leu-Ser). These adducts should behave analogously to the protein adduct in the Edman degradation. The adducts were characterized by nuclear magnetic resonance and fast atom bombardment and electrospray MS and tandem MS. Additionally, an analogous stable isotope-labeled standard was synthesized for the acrylonitrile adduct using a d8-labeled tripeptide. Quantitative calibration lines for analysis of the adducts have been established and the validity of the assays established by the detection of acrylonitrile adducts in the globin of acrylonitrile-exposed workers and of cigarette smokers.
Collapse
Affiliation(s)
- R M Lawrence
- MRC Toxicology Unit, University of Leicester, United Kingdom
| | | | | | | |
Collapse
|
49
|
Nahata MC, Bootman JL, Zadák Z, Soeters PB, Goldberg LA, Stremetzne S, Jaehde U, Streit M, Kreuser ED, Thiel E, Schunack W, Calvert RT, Feely M, Chrystyn H, Mangues MA, Ginovart G, Moral MA, Lopes AP, Farré R, Demestre X, Altirriba O, Kloft C, Beyer J, Steuer J, Siegert W, Bever J, Bialer M, Sussan S, Salach OA, Danenberg HD, Laor A, Barnett MI, Cosslett AG, Cohen J, Marini P, Bassi C, Bonzanini A, Cassani T, Ore G, Mangiante G, Scroccaro G, Kaczan M, Eriksen J, Toft B, Jandová M, Vlček J, Klemerová V, Sobotka L, Ayestarán A, López R, Montoro JB, Pou L, Estíbalez A, Pascual B, Aumente MD, Panadero MD, Caraballo M, Pozo JC, Perez JL, Falcão AC, Fernández de Gatta MM, Dominguez-Gil A, Caramona MM, Lanao JM, Fendrich Z, Zajic J, Bellés MMD, Casabó AVG, Jiménez TNV, Hervás BMA, Abad GFJ, Casterá MDE, Aminian M, Mangues MA, Clopés A, Branco C, Badell I, Pardo N, Palací C, Bonal J, Rialp G, Bara B, Nobilis M, Bláha V, Havel E, Květina J, Brátová M, Solichová D, Mullerova M, Svoboda D, Pokrajac M, Miljković B, Simić D, Brzaković B, Galetin A, Pinheiro RL, Carrondo AP, Sieradzki E, Strauss K, Olejarz E, Marzec A, Kaużny J, Szymura-Oleksiak J, Wyska E, Jarosz B, Kosowicz I, Fabirkiewicz K, Cherian R, Vodoz AL, Imsand B, Belli D, Rochat T, Müllerová H, Falcão F, Carvalho A, Pereira T, Fonseca C, Freitas O, Resende M, Parrinha A, Costa M, Pessanha MA, Ferreira A, Mourão L, Ceia F, Lima M, Tavares R, SalesLuis A, Carlos S, Pereira MEA, Carmo JAD, Lacerda JMF, Morais JA, Beaufils C, Duff M, Zamparutti P, Assicot P, Bohor M, Angelini B, Lambert M, Manelli JC, Gayte-Sorbier A, Bongrand MC, Timon-David P, Fiqueira IC, Lourenco R, Silva PA, Rodrigues MO, Fischer A, Schorr W, Radziwill R, Lihtamo M, Jäppinen A, Tuovinen K, Pekkala M, Nuutinen L, Morató L, Lorente L, Muñoz J, Monges P, Blancard A, Lacarelle B, Denis JP, Bongrand MC, Penot-Ragon C, Gouin F, Petitcollot N, Tinguely I, Beney J, Marty S, Reymond JP, Bussels J, Robays H, Litzinger A, Rohda-Bohler R, Salek MS, Turpin S, Derby E, Millar B, Maggs C, Santiago LM, Batel M, Cajaraville G, Tarnés MJ, Díaz MJ, Pozo C, Plazaola A, Vuelta M, Díaz-Munío E, Ferrer A, Lozano A, Guerra R, Pontón JL, Robays H, Kint K, Verstraetep A, Eini DE, Ojala RK, Kontra KM, Naaranlahti TJP, Martorell M, Oliveras M, Juste C, Lopez MT, Hidalgo E, Cabañas MJ, Barroso C, Llop JM, Rey M, Diaz-Munio E, Pastó L, Tubau M, Gómez-Bellver MJ, Rodriguez J, Gómez JM, Gónzalez ML, Gol V, Fuentes V, Ramón S, Girona L, Castelló T, Olona M, García L, Girón C, Monteserín C, Gonzalez P, Alberola C, Feio JAL, Pharm D, Batel Marques FJ, Borges AM, Salek S, Escoms MC, Caro I, Ticó N, Hidalgo M, Bruguera R, Jodar R, Dowell JM, Davey PG, Malek M, Díaz-Munío E, Vuelta M, Pastó L, Rev M, Ferrer I, Llop JM, Marti T, Ibars M, Delporte JP, Ansseau M, Albert A, Sibourg M, Gaspard O, Deprez M, Ndougsa HM, Poma M, Tamés MJ, Macek K, Vlček J, Fendrich Z, Klejna M, Dhillon S, Castro I, Newton M, Zupanets IA, Chernyh VP, Bezdetko NB, Popov SB, Velieva MN, Babajeya SM, Mamedov YD, Mammedov YD, Veliev PM, Nasudari AA, Bandalieva AA, Nordbo S, Smith-Solbakken M, Myklctun R, Berge W, Thormodsen M, Zupanets LA, Kicenko LS, Plusch SI, Isaev SG, Vokrouhlický L, Souček R, Kuneš P, Nývlt O, Potselueva LA, Egorova SN, Kadirova EA, Ziganshina LE, Chaloupka J, Genger K. Abstracts of papers and posters advanced activities in pharmaceutical care 24th European Symposium on Clinical Pharmacy. Pharm World Sci 1995. [PMCID: PMC7101703 DOI: 10.1007/bf01890522] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Download PDF] [Subscribe] [Scholar Register] [Indexed: 11/23/2022]
|
50
|
Tavares R, Daloze D, Braekman J, Hajdu E, Muricy G, Van Soest R. Isolation of crambescidin 800 from Monanchora arbuscula (Porifera). BIOCHEM SYST ECOL 1994. [DOI: 10.1016/0305-1978(94)90078-7] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|